Share on StockTwits

Cross Country Healthcare (NASDAQ:CCRN) General Counsel Susan E. Ball purchased 1,500 shares of the stock in a transaction dated Friday, June 6th. The shares were purchased at an average price of $6.72 per share, with a total value of $10,080.00. Following the completion of the acquisition, the general counsel now directly owns 122,438 shares of the company’s stock, valued at approximately $822,783. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Separately, analysts at Zacks downgraded shares of Cross Country Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, May 12th. They now have a $5.40 price target on the stock.

Shares of Cross Country Healthcare (NASDAQ:CCRN) traded up 2.96% during mid-day trading on Monday, hitting $6.95. The stock had a trading volume of 177,514 shares. Cross Country Healthcare has a 52 week low of $4.83 and a 52 week high of $11.54. The stock’s 50-day moving average is $6.27 and its 200-day moving average is $8.3. The company’s market cap is $216.2 million.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.01) by $0.02. The company had revenue of $118.10 million for the quarter, compared to the consensus estimate of $120.21 million. During the same quarter last year, the company posted ($0.01) earnings per share. Cross Country Healthcare’s revenue was up 7.0% compared to the same quarter last year. On average, analysts predict that Cross Country Healthcare will post $0.05 earnings per share for the current fiscal year.

Cross Country Healthcare, Inc (NASDAQ:CCRN) is engaged in the healthcare staffing services business offering a suite staffing and outsourcing services to the healthcare market.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.